PureTech Health (PRTC) Non Operating Investment Income (2023)
PureTech Health (PRTC) reported Non Operating Investment Income of -$61.8 million for Q4 2023.
PureTech Health (PRTC) Non Operating Investment Income (2023) Analysis & Trends
PureTech Health (PRTC) has 1 years of Non Operating Investment Income data on file, last reported at -$61.8 million in Q4 2023.
- Non Operating Investment Income for Q4 2023 came in at -$61.8 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was -$61.8 million (changed N/A YoY), and the FY2023 annual result was -$61.8 million, changed N/A from the prior year.
- Non Operating Investment Income held at -$61.8 million in Q4 2023 per PRTC's latest filing.
- Over five years, Non Operating Investment Income peaked at -$61.8 million in Q4 2023 and troughed at -$61.8 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 235,807.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 230,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | PureTech Health | 86.36 Mn | -190.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -61.79 Mn |
| Dec 31, 2023 | -61.79 Mn |